the use of new classes of intravesical agents , such as the interferons , and analogues of effective intravesical chemotherapies , such as epirubicin , the 4-epimer of doxorubicin , show promise of controlling the sequela of this common urologic problem .
C0014582
epirubicin
C0013089
doxorubicin